Manufacturer
Amgen Biopharmaceuticals Malaysia Sdn Bhd
Contents
Pegfilgrastim
Indication
Reduction in the duration of neutropenia & incidence of febrile neutropenia in patients treated w/ cytotoxic chemotherapy for malignancy (w/ exception of chronic myeloid leukemia & myelodysplastic syndromes).
Drug interaction
Myelosuppressive cytotoxic chemotherapeutic agents.
Malaysia
